Technology
Health
Medical

Neuronetics

$14.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (2.15%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!

About

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Employees
140
Headquarters
Malvern, Pennsylvania
Founded
2003
Market Cap
262.47M
Price-Earnings Ratio
Dividend Yield
Average Volume
124.94K
High Today
$14.83
Low Today
$14.01
Open Price
$14.26
Volume
18.25K
52 Week High
$39.39
52 Week Low
$13.26

Collections

Technology
Health
Medical
Therapy
Advertising and Marketing
Education
Business Services
2018 IPO

News

Yahoo FinanceMay 15

General Electric Co Buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc

- By insider Fairfield, CT, based Investment company General Electric Co buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, General Electric Co. As of 2019Q1, General Electric Co owns 5 stocks with a total value of $1.5 billion. These are the details of the buys and sells. New Purchases: WAB, STIM, For the details of GENERAL ELECTRIC CO's stock buys and sells, go to https://www.gurufocus...

3,520
Seeking AlphaMay 13

Neuronetics, Inc. CEO Chris Thatcher on Q1 2019 Results - Earnings Call Transcript

Neuronetics, Inc. (NASDAQ:STIM) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Mark Klausner - Investor Relations Chris Thatcher - Chief Executive Officer Peter Donato - Chief Financial Officer Conference Call Participants David Turkaly - JMP Securities Margaret Kaczor - William Blair Jason Mills - Canaccord Genuity Matthew O’Brien - Piper Jaffray Operator Good morning, ladies and gentlemen and welcome to the Q1 2019 Neuronetics Incorporated Earnings Call. At this ti...

20
NasdaqApr 23

Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release first quarter 2019 financial and operating results, and certain guidance for the second quarter and full year 2019, prior to market open on Tuesday, May 7, 2019. Chris Thatcher, Chief Executive Offi...

36

Earnings

-$30.60
-$20.50
-$10.39
-$0.29
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.40 per share
Actual
-$0.42 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.